Acute Myeloid Leukemia: Germany-wide clinical trial challenges international standard of care

Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML), complete remission is currently still considered the gold standard of care. A Germany-wide clinical trial now shows for the first time that this approach does not benefit disease-free survival or overall survival. An alternative approach of sequential conditioning followed by immediate stem cell transplantation may reduce side effects and shorten hospital stays.

Quelle: IDW Informationsdienst Wissenschaft